Cargando…
Association of Digoxin With Interstage Mortality: Results From the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Use Dataset
BACKGROUND: Mortality for infants with single ventricle congenital heart disease remains as high as 8% to 12% during the interstage period, the time between discharge after the Norwood procedure and before the stage II palliation. The objective of our study was to determine the association between d...
Autores principales: | Oster, Matthew E., Kelleman, Michael, McCracken, Courtney, Ohye, Richard G., Mahle, William T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4859374/ https://www.ncbi.nlm.nih.gov/pubmed/26764412 http://dx.doi.org/10.1161/JAHA.115.002566 |
Ejemplares similares
-
Association of Digoxin With Preserved Echocardiographic Indices in the Interstage Period: A Possible Mechanism to Explain Improved Survival?
por: Batsis, Maria, et al.
Publicado: (2021) -
Digoxin Use Is Associated With Reduced Interstage Mortality in Patients With No History of Arrhythmia After Stage I Palliation for Single Ventricle Heart Disease
por: Brown, David W., et al.
Publicado: (2016) -
Impact of Palliation Strategy on Interstage Feeding and Somatic Growth for Infants With Ductal‐Dependent Pulmonary Blood Flow: Results from the Congenital Catheterization Research Collaborative
por: Nicholson, George T., et al.
Publicado: (2019) -
Temporary bronchial stenting for airway compression in the interstage palliation of functional single ventricle
por: Barnes, Jason Hawes, et al.
Publicado: (2019) -
Decreasing Interstage Mortality After the Norwood Procedure: A 30‐Year Experience
por: Kaplinski, Michelle, et al.
Publicado: (2020)